摘要
前列腺癌是欧美男性最常见的恶性肿瘤,据美国癌症协会预测,2006年美国将新增234460例前列腺癌患者,而同期约有27350例患者死于该病。在美国,由于前列腺特异性抗原(PSA)作为筛查工具的广泛使用,临床局限性前列腺癌的检出明显增加,目前16%的患者在诊断时为局部高危病例。
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2006年第9期641-643,共3页
Chinese Journal of Urology
参考文献24
-
1Cooperberg MR, Moul JW,Carroll PR. The changing face of prostate cancer. J Clin Oncol,2005,23:8146-8151.
-
2Kramer BS, Brown ML, Prorok PC, et al.Prostate cancer screening: what we know and what we need to know. Ann Intern Med, 1993,119:914-923.
-
3Partin AW,Yoo J,Carter HB ,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.J Urol,1993,150:110-114.
-
4Perrapato SD, Carothers GG, Maatman TJ,et al. Comparing clinical staging plus transrectal ultrasound with surgical-pathologic staging of prostate cancer. Urology, 1989,33 :103-105.
-
5Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA, 1999,281 : 1598-1604.
-
6D'amico AV, Whittington R, Malkowicz SB,et al. Biochemical outcome after radical prostatectomy,external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA,1998,280 : 969-974.
-
7Partin AW, Mangold LA, Lamm DM, et al.Contemporary update of prostate cancer staging nomograms ( Partin Tables) for the new millennium. Urology, 2001,58: 843-848.
-
8Blute ML, Bergstralh EJ,Partin AW,et al.Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol, 2000, 164 : 1591-1595.
-
9Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol,2002,20 : 3206-3212.
-
10Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin ,2002,52 : 154-179.
同被引文献27
-
1许勇,杨勇,洪宝发.新辅助内分泌治疗在前列腺癌近距离放射治疗中的应用[J].老年医学与保健,2007,13(3):152-154. 被引量:2
-
2Jemal A , Siegel R , Ward E , et al. Cancer Statistics, 2007. CA Cancer J Clin ,2007,57:43 - 66.
-
3Pendleton J , Pisters LL , Nakamura K , et al. Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going. Urol Oncol,2007,25 : 11 - 18.
-
4Rafael Maldonado- Valadez , Dogu Teber , Tibet Erdogru , et al. The impact of neoadjuvant hormonal therapy on the outcome of laparoscopic radical prostatectomy : a matched pair analysis. J Urol, 2006, 175 (6) :2092 -2096.
-
5Swindle P , Eastham JA , Ohori M, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol,2005,174:903 - 907.
-
6Hsu CY , Joniau S , Van Poppel H , et al. Radical prostatectomy for locally advanced prostate cancer:technical aspects for radical prostatectomy. EAU update series,2005,3:90 -97.
-
7Hsu CY , Joniau S , Oyen R , et al. Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen - deprivation therapy. BJU Int,2007,99 (2) : 311-314.
-
8Nelson BA , Shappell SB , Chang SS , et al. Tumor volume is an independent predictor of prostate - specific antigen recurrence in patients undergoing radical prostateetomy for clinically localized prostate cancer. BJU Int,2006,97 : 1168 - 1172.
-
9Kllermann J, HopfenmUller W, Caprano J, et al. Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched - pair analysis. Eur Urol, 2004,45( 1 ) :42 -45.
-
10Denham JW , Steigler A , Lamb DS , et al. Short - term androgen deprivation and radiotherapy for locally advanced prostate cancer: Resuits from the Trans - Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol,2005, 6( 11 ) :841 - 850.
引证文献2
-
1茅叶青(综述),谢立平(审校),郑祥毅(审校).前列腺癌的新辅助治疗进展[J].国际泌尿系统杂志,2008,28(3):333-336.
-
2杨雄,金泓宇,宫丽娜,徐航,谭平,邱实,林天海,柳良仁,杨璐,魏强.以多西他赛为基础的新辅助化疗在前列腺癌中的应用进展[J].临床泌尿外科杂志,2021,36(2):120-125. 被引量:4
二级引证文献4
-
1刘郴郴,孙钦超,梁华庚,章小平(审校).近红外荧光成像技术在前列腺癌诊疗方面的应用进展[J].临床泌尿外科杂志,2021,36(11):904-908. 被引量:4
-
2耿惠,胡锋超,路洪超,郭军岗,齐增平.TPF方案同步IMRT治疗对中晚期食管癌患者免疫功能及生存预后的影响[J].国际肿瘤学杂志,2022,49(2):84-88. 被引量:3
-
3祁峰,李潇,徐维章,蔡宏宙,须霆,喻彬,邹青,徐子程.TP53基因突变在前列腺癌患者中的临床特征及预后价值[J].临床泌尿外科杂志,2022,37(12):906-910. 被引量:1
-
4陈林金,谢应玉,陈丹,林师雅.氧化苦参碱调控CDK4/cyclinD1通路诱导前列腺癌PC-3细胞凋亡的细胞周期调控机制[J].中国老年学杂志,2024,44(2):490-493. 被引量:3
-
1曾金光.小肠间质瘤的多层螺旋CT诊断价值研究[J].中国医学装备,2016,13(5):64-66. 被引量:7
-
2CT不适合筛查肺癌(1)[J].中国社区医师(医学专业),2008,10(16):107-107.
-
3刘红,张国楠.宫颈癌化疗耐药相关问题[J].中国实用妇科与产科杂志,2015,31(3):198-201. 被引量:19
-
4刘志,韩少良,黄颖鹏,武文一,李俊霖,薛向阳,沈贤.miR-143和miR-145在胃间质瘤组织中的表达及其意义[J].中华普通外科杂志,2010,25(8):678-680. 被引量:5
-
5刘全达,苟欣,何卫阳.前列腺癌筛查研究进展[J].国际泌尿系统杂志,2016,0(2):257-261. 被引量:1
-
6王夕富,白人驹.肿瘤微血管密度及其与医学影像学的相关研究[J].国外医学(临床放射学分册),2004,27(6):337-340. 被引量:2
-
7张永,于甬华,于金明,付政,郭守芳,刘希军,丛昌盛.^18FDG PET-CT在非小细胞肺癌放化疗后疗效评估中的应用[J].中华放射肿瘤学杂志,2009,18(3):180-181. 被引量:1
-
8常婷婷,马文进,王翎.肺癌筛查指标的研究进展[J].现代预防医学,2011,38(11):2147-2149. 被引量:2
-
9李永杰,陈倬,周艳敏.彩超在老年人浅表淋巴结肿大筛查中的价值[J].武警医学院学报,2009,18(9):773-774. 被引量:1
-
10周英.阴道镜检查在宫颈癌筛查中的诊断价值探讨[J].今日健康,2015,14(11):418-419. 被引量:1